...
nvo-img

Novo Nordisk A/S, Common Stock

NVO

NYQ

$103.275

-$2.68

(-2.53%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$486.49B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
36.1237
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.17M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
1.34%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.17
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$99.42 L
$147.59 H
$103.275

About Novo Nordisk A/S, Common Stock

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameNVOSectorS&P500
1-Week Return-5.13%-3.39%-3.47%
1-Month Return6.16%-3.25%-0.29%
3-Month Return-19.76%-11.61%4.5%
6-Month Return-24.74%-5.89%6.91%
1-Year Return7.05%2.65%23.79%
3-Year Return104.69%0.56%28.43%
5-Year Return272.77%34.63%83.64%
10-Year Return377.3%94.78%185.94%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue122.02B126.95B140.80B176.95B232.26B[{"date":"2019-12-31","value":52.54,"profit":true},{"date":"2020-12-31","value":54.66,"profit":true},{"date":"2021-12-31","value":60.62,"profit":true},{"date":"2022-12-31","value":76.19,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue20.09B20.93B23.66B28.45B35.77B[{"date":"2019-12-31","value":56.17,"profit":true},{"date":"2020-12-31","value":58.53,"profit":true},{"date":"2021-12-31","value":66.15,"profit":true},{"date":"2022-12-31","value":79.54,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit101.93B106.01B117.14B148.51B196.50B[{"date":"2019-12-31","value":51.88,"profit":true},{"date":"2020-12-31","value":53.95,"profit":true},{"date":"2021-12-31","value":59.62,"profit":true},{"date":"2022-12-31","value":75.58,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin83.54%83.51%83.20%83.92%84.60%[{"date":"2019-12-31","value":98.74,"profit":true},{"date":"2020-12-31","value":98.71,"profit":true},{"date":"2021-12-31","value":98.34,"profit":true},{"date":"2022-12-31","value":99.2,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses49.45B51.89B58.50B73.70B93.92B[{"date":"2019-12-31","value":52.65,"profit":true},{"date":"2020-12-31","value":55.25,"profit":true},{"date":"2021-12-31","value":62.28,"profit":true},{"date":"2022-12-31","value":78.47,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income52.48B54.13B58.64B74.81B102.57B[{"date":"2019-12-31","value":51.17,"profit":true},{"date":"2020-12-31","value":52.77,"profit":true},{"date":"2021-12-31","value":57.17,"profit":true},{"date":"2022-12-31","value":72.93,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Total Non-Operating Income/Expense(4.37B)(1.20B)256.00M(6.07B)2.43B[{"date":"2019-12-31","value":-179.67,"profit":false},{"date":"2020-12-31","value":-49.34,"profit":false},{"date":"2021-12-31","value":10.53,"profit":true},{"date":"2022-12-31","value":-249.67,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income48.55B53.13B59.08B69.06B104.67B[{"date":"2019-12-31","value":46.38,"profit":true},{"date":"2020-12-31","value":50.76,"profit":true},{"date":"2021-12-31","value":56.44,"profit":true},{"date":"2022-12-31","value":65.98,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income Taxes9.60B10.99B11.32B13.54B20.99B[{"date":"2019-12-31","value":45.74,"profit":true},{"date":"2020-12-31","value":52.37,"profit":true},{"date":"2021-12-31","value":53.94,"profit":true},{"date":"2022-12-31","value":64.49,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes38.95B42.14B47.76B55.52B83.68B[{"date":"2019-12-31","value":46.55,"profit":true},{"date":"2020-12-31","value":50.35,"profit":true},{"date":"2021-12-31","value":57.07,"profit":true},{"date":"2022-12-31","value":66.35,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income From Continuous Operations38.95B42.14B47.76B55.52B83.68B[{"date":"2019-12-31","value":46.55,"profit":true},{"date":"2020-12-31","value":50.35,"profit":true},{"date":"2021-12-31","value":57.07,"profit":true},{"date":"2022-12-31","value":66.35,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income38.95B42.14B47.76B55.52B83.68B[{"date":"2019-12-31","value":46.55,"profit":true},{"date":"2020-12-31","value":50.35,"profit":true},{"date":"2021-12-31","value":57.07,"profit":true},{"date":"2022-12-31","value":66.35,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
EPS (Diluted)1.221.391.641.732.74[{"date":"2019-12-31","value":44.61,"profit":true},{"date":"2020-12-31","value":50.86,"profit":true},{"date":"2021-12-31","value":59.82,"profit":true},{"date":"2022-12-31","value":63.14,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

NVO
Cash Ratio 0.36
Current Ratio 0.94
Quick Ratio 0.75

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

NVO
ROA (LTM) 21.47%
ROE (LTM) 88.73%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

NVO
Debt Ratio Lower is generally better. Negative is bad. 0.70
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.30

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

NVO
Trailing PE 36.12
Forward PE 27.55
P/S (TTM) 1.80
P/B 28.23
Price/FCF 16
EV/R 12.69
EV/Ebitda 25.20
PEG 1.61

FAQs

What is Novo Nordisk A/S share price today?

Novo Nordisk A/S (NVO) share price today is $103.275

Can Indians buy Novo Nordisk A/S shares?

Yes, Indians can buy shares of Novo Nordisk A/S (NVO) on Vested. To buy Novo Nordisk A/S from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in NVO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Novo Nordisk A/S be purchased?

Yes, you can purchase fractional shares of Novo Nordisk A/S (NVO) via the Vested app. You can start investing in Novo Nordisk A/S (NVO) with a minimum investment of $1.

How to invest in Novo Nordisk A/S shares from India?

You can invest in shares of Novo Nordisk A/S (NVO) via Vested in three simple steps:

  • Click on Sign Up or Invest in NVO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Novo Nordisk A/S shares
What is Novo Nordisk A/S 52-week high and low stock price?

The 52-week high price of Novo Nordisk A/S (NVO) is $147.59. The 52-week low price of Novo Nordisk A/S (NVO) is $99.42.

What is Novo Nordisk A/S price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Novo Nordisk A/S (NVO) is 36.1237

What is Novo Nordisk A/S price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Novo Nordisk A/S (NVO) is 28.23

What is Novo Nordisk A/S dividend yield?

The dividend yield of Novo Nordisk A/S (NVO) is 1.34%

What is the Market Cap of Novo Nordisk A/S?

The market capitalization of Novo Nordisk A/S (NVO) is $486.49B

What is Novo Nordisk A/S’s stock symbol?

The stock symbol (or ticker) of Novo Nordisk A/S is NVO

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top